Pulmonary embolism and Muscle function loss

Summary:

Muscle function loss is found among people with Pulmonary embolism, especially for people who are female, 60+ old.

The study analyzes which people have Muscle function loss with Pulmonary embolism. It is created by eHealthMe based on reports of 16 people who have Pulmonary embolism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,333 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

What is Muscle function loss?

Muscle function loss is found to be associated with 1,001 drugs and 1,521 conditions by eHealthMe. Check the latest studies of Muscle function loss.



On Jul, 09, 2026

16 people who have Pulmonary Embolism and Muscle Function Loss are studied.

Would you have Muscle function loss when you have Pulmonary embolism?

Gender of people who have Pulmonary Embolism and experienced Muscle Function Loss *:

  • female: 60 %
  • male: 40 %

Age of people who have Pulmonary Embolism and experienced Muscle Function Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.33 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 58.33 %

Common co-existing conditions for these people *:

  1. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 31.25%
  2. Asthma: 2 people, 12.50%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
  4. Pain: 2 people, 12.50%
  5. Weakness: 1 person, 6.25%
  6. Embolism Venous (embolus may pass into the arterial system): 1 person, 6.25%
  7. High Blood Cholesterol: 1 person, 6.25%
  8. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 6.25%
  9. Gastric Ulcer (stomach ulcer): 1 person, 6.25%
  10. Fainting (loss of consciousness and postural tone): 1 person, 6.25%

Common drugs taken by these people *:

  1. Eliquis: 7 people, 43.75%
  2. Xarelto: 3 people, 18.75%
  3. Lopressor: 2 people, 12.50%
  4. Vyvanse: 2 people, 12.50%
  5. Nexium: 2 people, 12.50%
  6. Coumadin: 2 people, 12.50%
  7. Clopidogrel: 1 person, 6.25%
  8. Lasix: 1 person, 6.25%
  9. Gemcitabine: 1 person, 6.25%
  10. Fish Oil: 1 person, 6.25%

Common symptoms for these people *:

  1. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 3 people, 18.75%
  2. Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 18.75%
  3. Weakness: 2 people, 12.50%
  4. Carotid Artery Occlusion (artery blockage): 2 people, 12.50%
  5. Haemorrhage (bleeding): 2 people, 12.50%
  6. Haemorrhagic Ascites (abnormal accumulation of fluid in the abdomen with blood): 2 people, 12.50%
  7. Gait Disturbance: 2 people, 12.50%
  8. Heavy Or Prolong Menstrual Bleeding: 2 people, 12.50%
  9. Immunodeficiency: 2 people, 12.50%
  10. Dizziness: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Muscle function loss?

- Check whether Muscle function loss is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Muscle function loss:

All the conditions that are associated with Muscle function loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Muscle function loss and Pulmonary embolism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: